TXNDC5 and carotid atherosclerosis: Yeh et al. has recently utilized nanoparticles carrying an endothelium-specific Txndc5-targeting CRISPR/Cas9 vectors to specifically delete endothelial TXNDC5, which effectively ameliorates disturbed blood flow-induced carotid atherosclerosis [22].